1. Anti-infection
    Metabolic Enzyme/Protease
  2. HCV
    HCV Protease
    SARS-CoV
  3. Narlaprevir

Narlaprevir (Synonyms: SCH 900518)

Cat. No.: HY-10300 Purity: 98.15%
Handling Instructions

Narlaprevir (SCH 900518) is a selective and orally bioavailable NS3 protease inhibitor with a Ki value of 6 nM and an EC90 value of 40 nM. Narlaprevir also inhibits the HCV nonstructural protein 3 serine protease. Narlaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 2.3 μM.

For research use only. We do not sell to patients.

Narlaprevir Chemical Structure

Narlaprevir Chemical Structure

CAS No. : 865466-24-6

Size Price Stock Quantity
Solution
10 mM * 1 mL in DMSO USD 737 In-stock
Estimated Time of Arrival: December 31
Solid + Solvent
10 mM * 1 mL
ready for reconstitution
USD 737 In-stock
Estimated Time of Arrival: December 31
Solid
10 mg USD 670 In-stock
Estimated Time of Arrival: December 31
50 mg USD 1085 In-stock
Estimated Time of Arrival: December 31
100 mg USD 1896 In-stock
Estimated Time of Arrival: December 31
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

Customer Review

Based on 3 publication(s) in Google Scholar

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Narlaprevir (SCH 900518) is a selective and orally bioavailable NS3 protease inhibitor with a Ki value of 6 nM and an EC90 value of 40 nM[1]. Narlaprevir also inhibits the HCV nonstructural protein 3 serine protease[2]. Narlaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 2.3 μM[3].

IC50 & Target

Ki: 6 nM (NS3 protease) [1]
EC90: 40 nM (NS3 protease) [1]
Ki: 7 nM (ketoamide) [2]
EC90: 40 nM (replicon RNA) [2]

In Vitro

Narlaprevir (SCH 900518) potently inhibits ketoamide with a Ki value of 7 nM[2].
Narlaprevir (SCH 900518) potently inhibits replicon RNA with an EC90 value of 40 nM[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Pharmacokinetic Analysis
Narlaprevir (SCH 900518) exhibits middle oral bioavailability (rat 46%, dog 29%, monkey 46 %) following oral administration (rat 10 mg/kg, dog 3 mg/kg, monkey 3 mg/kg )[1].
Narlaprevir (SCH 900518) exhibits moderate half-lives (rat 4.8 and dog 2 h) following intravenous administration (rat 4 and dog 1 mg/kg)[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: rats, dogs, monkeys[1]
Dosage: Rat PO/IV 10/4 mg/kg; dog PO/IV 3/1 mg/kg; monkey PO 3 mg/kg
Administration: Intravenous (i.v.) or oral gavage
Result: T1/2s of 4.8 and 2 h for rats and dogs, respectively.
Clinical Trial
Molecular Weight

707.96

Formula

C₃₆H₆₁N₅O₇S

CAS No.
Shipping

Room temperature in continental US; may vary elsewhere.

Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Solvent & Solubility
In Vitro: 

DMSO : ≥ 50 mg/mL (70.63 mM)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.4125 mL 7.0625 mL 14.1251 mL
5 mM 0.2825 mL 1.4125 mL 2.8250 mL
10 mM 0.1413 mL 0.7063 mL 1.4125 mL
*Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.5 mg/mL (3.53 mM); Clear solution

  • 2.

    Add each solvent one by one:  10% DMSO    90% corn oil

    Solubility: ≥ 2.5 mg/mL (3.53 mM); Clear solution

*All of the co-solvents are provided by MCE.
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email address *

Phone number *

 

Organization name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Narlaprevir
Cat. No.:
HY-10300
Quantity:
MCE Japan Authorized Agent: